Skip to main content
logo
Aldeyra Therapeutics, Inc. (ALDX)
NASDAQ: ALDX · Real-Time Price · USD
0.6502
+0.0343 (5.57%)
Nov 6, 2026, 12:19 PM EST - Market open

Aldeyra Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
39312297206408232
Market Cap Growth
-87.48%4.88%43.92%-49.34%75.40%-12.74%
Enterprise Value
-625224079260132
Last Close Price
0.625.184.993.516.964.00

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-16.3213.27---
PB Ratio
0.987.044.181.722.701.13
P/TBV Ratio
0.987.044.181.722.701.13

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.000.350.220.130.110.08
Net Debt / Equity Ratio
-1.19-1.23-1.21-1.06-1.05-0.43
Net Debt / EBITDA Ratio
1.891.561.432.992.541.59
Net Debt / FCF Ratio
2.041.641.994.192.792.09
Quick Ratio
4.672.525.446.4211.568.90
Current Ratio
4.912.585.606.6411.7919.77
Return on Equity (ROE)
-49.48%-58.73%-58.54%-27.73%-34.77%-43.56%
Return on Assets (ROA)
-22.70%-24.95%-29.71%-16.23%-18.91%-22.20%
Return on Capital Employed (ROCE)
-63.50%-79.70%-69.90%-33.90%-37.80%-25.40%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-58.86%-10.86%-18.80%-18.18%-15.22%-24.86%
FCF Yield
-59.33%-10.70%-14.54%-14.69%-13.90%-18.32%
Buyback Yield / Dilution
-0.79%-0.96%-0.92%-0.92%-8.08%-59.11%
SEC Filings: 10-K · 10-Q